Testosterone pellet implants and migraine headaches: a pilot study

Area of Science:

• Neurology
• Endocrinology
• Women's Health

Background:

• Migraine headaches represent a significant neurological disorder impacting quality of life.
• Hormonal fluctuations, particularly in women, are often linked to migraine onset and severity.
• Current treatments for migraine may have limitations or side effects, necessitating exploration of alternative therapies.

Purpose of the Study:

• To evaluate the efficacy of continuous subcutaneous testosterone implants in mitigating migraine severity.
• To assess the therapeutic effect of testosterone therapy in both pre- and post-menopausal women experiencing migraines.

Main Methods:

• Prospective pilot study involving 27 women with a history of diagnosed migraine headaches.
• Participants rated headache severity on a 5-point scale at baseline and 3 months post-testosterone implant therapy.
• Comparison of treatment outcomes between pre- and post-menopausal patient groups.

Main Results:

• A statistically significant improvement in migraine headache severity was observed in 92% of participants.
• The average improvement in headache severity was 3.3 on a 5-point scale.
• No significant difference in improvement levels was noted between pre- and post-menopausal cohorts; 74% reported a severity score of '0' (none).

Conclusions:

• Continuous subcutaneous testosterone implants are an effective therapeutic option for reducing migraine severity in women.
• Testosterone therapy demonstrates consistent benefits for migraine relief in both pre- and post-menopausal women.
• Further research is warranted to explore long-term efficacy and optimal dosing of testosterone implants for migraine management.